Candidates in context
Move from a suggestion to its location in the CT study.
FOR RADIOLOGISTS
You bring the experience, the clinical context and the judgment. We’re building a second-reader experience to support the care and attention you already bring to every study.

AI findings should be visible, understandable and easy to review. Your interpretation remains the final one.
BUILT AROUND YOUR REVIEW
Move from a suggestion to its location in the CT study.
A considered candidate list, designed to support attention.
Inspect, accept or dismiss. The interpretation is yours.
Visible regions and clear review states, rather than a hidden verdict.
WHAT YOU WOULD SEE
Select a candidate in the illustrative workspace, inspect its location, and try the accept and dismiss controls.

A product concept with fictional annotations, confidence labels and study identifiers. The controls demonstrate interaction design; they do not analyze the image.
A FEW IMPORTANT DISTINCTIONS
No. The intended role is to present pulmonary nodule candidates for radiologist review. Clinical interpretation, reporting and decisions remain with the clinician.
The platform is in development. Clinical performance has not been published, and the site does not claim regulatory authorization. Any clinical use would depend on appropriate validation and applicable regulatory requirements.
The confidence labels in the demo are fictional interface examples. In a validated product, a candidate score would need clear interpretation and documented limitations. It would not be a probability of cancer.
PACS/RIS interoperability and deployment flexibility are design directions. Specific integrations are not available or promised by this website; they will be scoped with prospective partners.
We welcome conversations about candidate presentation, review burden, clinical evaluation and workflow fit. The first step is a discussion about your setting and research interests.
LET’S BUILD THE NEXT CHAPTER
We’re looking to collaborate with radiologists, imaging centers
and clinical research partners.